302 related articles for article (PubMed ID: 30712978)
21. Dietary Glycotoxins, Advanced Glycation End Products, Inhibit Cell Proliferation and Progesterone Secretion in Ovarian Granulosa Cells and Mimic PCOS-like Symptoms.
Lin PH; Chang CC; Wu KH; Shih CK; Chiang W; Chen HY; Shih YH; Wang KL; Hong YH; Shieh TM; Hsia SM
Biomolecules; 2019 Jul; 9(8):. PubMed ID: 31370285
[TBL] [Abstract][Full Text] [Related]
22. sRAGE plays a role as a protective factor in the development of PCOS by inhibiting inflammation.
Wang BJ; Qian L; Li J; Wang F; Yang QL; Li G; Liang YL; Guo YH
Gynecol Endocrinol; 2020 Feb; 36(2):148-151. PubMed ID: 31248316
[TBL] [Abstract][Full Text] [Related]
23. Methylglyoxal-Dependent Glycative Stress and Deregulation of SIRT1 Functional Network in the Ovary of PCOS Mice.
Emidio GD; Placidi M; Rea F; Rossi G; Falone S; Cristiano L; Nottola S; D'Alessandro AM; Amicarelli F; Palmerini MG; Tatone C
Cells; 2020 Jan; 9(1):. PubMed ID: 31947651
[TBL] [Abstract][Full Text] [Related]
24. Metabolic consequences of obesity and insulin resistance in polycystic ovary syndrome: diagnostic and methodological challenges.
Jeanes YM; Reeves S
Nutr Res Rev; 2017 Jun; 30(1):97-105. PubMed ID: 28222828
[TBL] [Abstract][Full Text] [Related]
25. Hyperandrogenemia and insulin resistance: The chief culprit of polycystic ovary syndrome.
Wang J; Wu D; Guo H; Li M
Life Sci; 2019 Nov; 236():116940. PubMed ID: 31604107
[TBL] [Abstract][Full Text] [Related]
26. Impact of Dietary Advanced Glycation End Products on Female Reproduction: Review of Potential Mechanistic Pathways.
Mouanness M; Merhi Z
Nutrients; 2022 Feb; 14(5):. PubMed ID: 35267940
[TBL] [Abstract][Full Text] [Related]
27. Role of advanced glycation end products and insulin resistance in diabetic nephropathy.
Parwani K; Mandal P
Arch Physiol Biochem; 2023 Feb; 129(1):95-107. PubMed ID: 32730131
[TBL] [Abstract][Full Text] [Related]
28. Assay for advanced glycation end products generating intracellular oxidative stress through binding to its receptor.
Kobori T; Ganesh D; Kumano-Kuramochi M; Torigoe K; Machida S
Anal Biochem; 2020 Dec; 611():114018. PubMed ID: 33186591
[TBL] [Abstract][Full Text] [Related]
29. Decreased levels of sRAGE in follicular fluid from patients with PCOS.
Wang B; Li J; Yang Q; Zhang F; Hao M; Guo Y
Reproduction; 2017 Mar; 153(3):285-292. PubMed ID: 27965400
[TBL] [Abstract][Full Text] [Related]
30. Environmental toxin exposure in polycystic ovary syndrome women and possible ovarian neoplastic repercussion.
Soave I; Occhiali T; Assorgi C; Marci R; Caserta D
Curr Med Res Opin; 2020 Apr; 36(4):693-703. PubMed ID: 32046531
[No Abstract] [Full Text] [Related]
31. Implication of advanced glycation end products (Ages) and their receptor (Rage) on myocardial contractile and mitochondrial functions.
Neviere R; Yu Y; Wang L; Tessier F; Boulanger E
Glycoconj J; 2016 Aug; 33(4):607-17. PubMed ID: 27277623
[TBL] [Abstract][Full Text] [Related]
32. Advanced glycation end products and insulin resistance.
Unoki H; Yamagishi S
Curr Pharm Des; 2008; 14(10):987-9. PubMed ID: 18473850
[TBL] [Abstract][Full Text] [Related]
33. Accumulation of Advanced Glycation End Products Involved in Inflammation and Contributing to Severe Preeclampsia, in Maternal Blood, Umbilical Blood and Placental Tissues.
Chen W; Zhang Y; Yue C; Ye Y; Chen P; Peng W; Wang Y
Gynecol Obstet Invest; 2017; 82(4):388-397. PubMed ID: 27505171
[TBL] [Abstract][Full Text] [Related]
34. Vitamin D increases serum levels of the soluble receptor for advanced glycation end products in women with PCOS.
Irani M; Minkoff H; Seifer DB; Merhi Z
J Clin Endocrinol Metab; 2014 May; 99(5):E886-90. PubMed ID: 24606102
[TBL] [Abstract][Full Text] [Related]
35. Impact of Advanced Glycation End products (AGEs) and its receptor (RAGE) on cancer metabolic signaling pathways and its progression.
Muthyalaiah YS; Jonnalagadda B; John CM; Arockiasamy S
Glycoconj J; 2021 Dec; 38(6):717-734. PubMed ID: 35064413
[TBL] [Abstract][Full Text] [Related]
36. Phenotypes and enviromental factors: their influence in PCOS.
Diamanti-Kandarakis E; Christakou C; Marinakis E
Curr Pharm Des; 2012; 18(3):270-82. PubMed ID: 22229564
[TBL] [Abstract][Full Text] [Related]
37. JNK and ATF4 as two important platforms for tumor necrosis factor-α-stimulated shedding of receptor for advanced glycation end products.
Miyoshi A; Koyama S; Sasagawa-Monden M; Kadoya M; Konishi K; Shoji T; Inaba M; Yamamoto Y; Koyama H
FASEB J; 2019 Mar; 33(3):3575-3589. PubMed ID: 30452882
[TBL] [Abstract][Full Text] [Related]
38. Peri-muscular adipose tissue may play a unique role in determining insulin sensitivity/resistance in women with polycystic ovary syndrome.
Morrison SA; Goss AM; Azziz R; Raju DA; Gower BA
Hum Reprod; 2017 Jan; 32(1):185-192. PubMed ID: 27827322
[TBL] [Abstract][Full Text] [Related]
39. Divergent Changes in Plasma AGEs and sRAGE Isoforms Following an Overnight Fast in T1DM.
Miranda ER; Fuller KNZ; Perkins RK; Beisswenger PJ; Farabi SS; Quinn L; Haus JM
Nutrients; 2019 Feb; 11(2):. PubMed ID: 30781793
[TBL] [Abstract][Full Text] [Related]
40. Advanced Glycation End Products (AGEs), Glutathione and Breast Cancer: Factors, Mechanism and Therapeutic Interventions.
Sharma AK; Sharma VR; Gupta GK; Ashraf GM; Kamal MA
Curr Drug Metab; 2019; 20(1):65-71. PubMed ID: 30207227
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
